|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 235/06 | (2006.01) |
| A61K 31/4184 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1968948 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06840192.6 |
| Date of filing the European patent application | 2006-12-12 | |
| (97) | Date of publication of the European application | 2008-09-17 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-22 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (86) | Number | PCT/US2006/061895 |
| Date | 2006-12-12 |
| (87) | Number | WO 2007/076245 |
| Date | 2007-07-05 |
| (30) | Number | Date | Country code |
| 752781 P | 2005-12-21 | US |
| (72) |
SQUIRE, Christopher, John, GB
DEMATTEI, John, US
ROBERTS, Ronald, John, GB
CHUANG, Tsung-hsun, US
SHARMA-SINGH, Gorkhn, GB
PERVEZ, Mohammed, GB
FORD, James, Gair, GB
STOREY, Richard, Anthony, GB
DICKINSON, Paul, Alfred, GB
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
AstraZeneca AB, 151 85 Södertälje, SE |
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Nauja vandenilio sulfato druska |
| NOVEL HYDROGEN SULFATE SALT |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 19 | 347.00 EUR |
| 2025-12-12 |